Chemical Industry and Engineering Progress ›› 2019, Vol. 38 ›› Issue (05): 2389-2401.DOI: 10.16085/j.issn.1000-6613.2018-1482
• Biochemical and pharmaceutical engineering • Previous Articles Next Articles
Zeren SHANG1,2,3(),Weiguo HU1,2,3,4,Weiwei TANG1,2,3,Lina JIA1,2,3,Mingchen LI1,2,3,Yanxiao ZHAO1,2,3,Ning WEI1,2,3,Junbo GONG1,2,3()
Received:
2018-07-17
Revised:
2019-01-03
Online:
2019-05-05
Published:
2019-05-05
Contact:
Junbo GONG
尚泽仁1,2,3(),胡卫国1,2,3,4,汤伟伟1,2,3,贾丽娜1,2,3,李鸣晨1,2,3,赵燕晓1,2,3,魏宁1,2,3,龚俊波1,2,3()
通讯作者:
龚俊波
作者简介:
<named-content content-type="corresp-name">尚泽仁</named-content>(1994—),男,硕士研究生,研究方向为药物晶体工程。E-mail:<email>shangzeren@tju.edu.cn</email>。
基金资助:
CLC Number:
Zeren SHANG, Weiguo HU, Weiwei TANG, Lina JIA, Mingchen LI, Yanxiao ZHAO, Ning WEI, Junbo GONG. Application of ionic liquids in pharmaceutical crystal engineering[J]. Chemical Industry and Engineering Progress, 2019, 38(05): 2389-2401.
尚泽仁, 胡卫国, 汤伟伟, 贾丽娜, 李鸣晨, 赵燕晓, 魏宁, 龚俊波. 离子液体在药物晶体工程中的应用[J]. 化工进展, 2019, 38(05): 2389-2401.
Add to citation manager EndNote|Ris|BibTeX
URL: https://hgjz.cip.com.cn/EN/10.16085/j.issn.1000-6613.2018-1482
药物名称 | 晶型 | 临床疗效 | 文献 |
---|---|---|---|
甲苯达唑 | 晶型A,晶型B,晶型C | 晶型C > 晶型A | [ |
法莫替丁 | 晶型A,晶型B,晶型C,晶型D | 晶型B > 晶型A | [ |
棕榈氯霉素 | 晶型A,晶型B,晶型C | 晶型B和晶型C > 晶型A | [ |
尼群地平 | 晶型Ⅰ,晶型Ⅱ,晶型Ⅲ,晶型Ⅳ | 晶型Ⅳ > 晶型Ⅰ | [ |
利福定 | 晶型Ⅰ,晶型Ⅱ,晶型Ⅲ,晶型Ⅳ | 晶型Ⅳ > 晶型Ⅱ | [ |
药物名称 | 晶型 | 临床疗效 | 文献 |
---|---|---|---|
甲苯达唑 | 晶型A,晶型B,晶型C | 晶型C > 晶型A | [ |
法莫替丁 | 晶型A,晶型B,晶型C,晶型D | 晶型B > 晶型A | [ |
棕榈氯霉素 | 晶型A,晶型B,晶型C | 晶型B和晶型C > 晶型A | [ |
尼群地平 | 晶型Ⅰ,晶型Ⅱ,晶型Ⅲ,晶型Ⅳ | 晶型Ⅳ > 晶型Ⅰ | [ |
利福定 | 晶型Ⅰ,晶型Ⅱ,晶型Ⅲ,晶型Ⅳ | 晶型Ⅳ > 晶型Ⅱ | [ |
名称 | 英文缩写 | CAS # | 结构 |
---|---|---|---|
1-丁基-3-甲基咪唑双三氟甲磺酰亚胺盐 | [C4mim][N(CF3SO2)2] | 174899-83-3 | |
1-己基-3-甲基咪唑双三氟甲磺酰亚胺盐 | [C6mim][N(CF3SO2)2] | 382150-50-7 | |
1-丁基-3-甲基咪唑四氟硼酸盐 | [C4mim][BF4] | 174501-65-6 | |
1-己基-3-甲基咪唑四氟硼酸盐 | [C6mim][BF4] | 244193-50-8 | |
1-烯丙基-3-乙基咪唑四氟硼酸盐 | [aeim][BF4] | 945732-42-3 | |
1-丁基-2,3-二甲基咪唑四氟硼酸盐 | [bdmim][BF4] | 402846-78-0 | |
1,3-二烯丙基咪唑四氟硼酸盐 | [aaim][BF4] | 852699-06-0 | |
1-乙基-3-甲基咪唑硫酸乙酯盐 | [emim][EtSO4] | 342573-75-5 | |
1-丁基-3-甲基咪唑六氟磷酸盐 | [bmim][PF6] | 174501-64-5 | |
1-乙基-3-甲基咪唑甲基磷酸酯盐 | [emim][CH3O(H)PO2] | 81994-80-1 | |
1-己基-3-甲基咪唑六氟磷酸盐 | [hmim][PF6] | 304680-35-1 | |
1-乙基-3-甲基咪唑乙酸盐 | [C2mim][OAc] | 143314-17-4 | |
1-丁基-3-甲基咪唑溴盐 | [C4mim]Br | 85100-77-2 | |
三己基(十四烷基)鏻双(草酸根)硼酸盐 | [P6,6,6,14][BOB] | 880497-87-0 | |
名称 | 英文缩写 | CAS # | 结构 |
---|---|---|---|
1-丁基-3-甲基咪唑双三氟甲磺酰亚胺盐 | [C4mim][N(CF3SO2)2] | 174899-83-3 | |
1-己基-3-甲基咪唑双三氟甲磺酰亚胺盐 | [C6mim][N(CF3SO2)2] | 382150-50-7 | |
1-丁基-3-甲基咪唑四氟硼酸盐 | [C4mim][BF4] | 174501-65-6 | |
1-己基-3-甲基咪唑四氟硼酸盐 | [C6mim][BF4] | 244193-50-8 | |
1-烯丙基-3-乙基咪唑四氟硼酸盐 | [aeim][BF4] | 945732-42-3 | |
1-丁基-2,3-二甲基咪唑四氟硼酸盐 | [bdmim][BF4] | 402846-78-0 | |
1,3-二烯丙基咪唑四氟硼酸盐 | [aaim][BF4] | 852699-06-0 | |
1-乙基-3-甲基咪唑硫酸乙酯盐 | [emim][EtSO4] | 342573-75-5 | |
1-丁基-3-甲基咪唑六氟磷酸盐 | [bmim][PF6] | 174501-64-5 | |
1-乙基-3-甲基咪唑甲基磷酸酯盐 | [emim][CH3O(H)PO2] | 81994-80-1 | |
1-己基-3-甲基咪唑六氟磷酸盐 | [hmim][PF6] | 304680-35-1 | |
1-乙基-3-甲基咪唑乙酸盐 | [C2mim][OAc] | 143314-17-4 | |
1-丁基-3-甲基咪唑溴盐 | [C4mim]Br | 85100-77-2 | |
三己基(十四烷基)鏻双(草酸根)硼酸盐 | [P6,6,6,14][BOB] | 880497-87-0 | |
名称英文缩写 | 熔点/°C | 黏度25℃/Pa?s | 亲水/疏水 |
---|---|---|---|
[C4mim][N(CF3SO2)2] | -4.9 | 0.0511 | 亲水 |
[C6mim][N(CF3SO2)2] | -10.5 | 0.0705 | 亲水 |
[C4mim][BF4] | -17.0 | 0.0949 | 亲水 |
[C6mim][BF4] | -81.0 | 0.1456 | 疏水 |
[aeim][BF4] | — | — | 亲水 |
[bdmim][BF4] | 39.7 | 0.6500 | 亲水 |
[aaim][BF4] | 4.3 | — | 亲水 |
[emim][EtSO4] | -65.0 | 0.0962 | 亲水 |
[bmim][PF6] | 10.9 | 0.2740 | 疏水 |
[emim][CH3O(H)PO2] | — | 0.1564 ① | 亲水 |
[hmim][PF6] | -80.0 | 0.4830 | 疏水 |
[C2mim][OAc] | < -20.0 | 0.1285 | 亲水 |
[C4mim]Br | 72.9 | 0.0570 ② | 亲水 |
[P6,6,6,14][BOB] | — | 0.6150 ① | 亲水 |
名称英文缩写 | 熔点/°C | 黏度25℃/Pa?s | 亲水/疏水 |
---|---|---|---|
[C4mim][N(CF3SO2)2] | -4.9 | 0.0511 | 亲水 |
[C6mim][N(CF3SO2)2] | -10.5 | 0.0705 | 亲水 |
[C4mim][BF4] | -17.0 | 0.0949 | 亲水 |
[C6mim][BF4] | -81.0 | 0.1456 | 疏水 |
[aeim][BF4] | — | — | 亲水 |
[bdmim][BF4] | 39.7 | 0.6500 | 亲水 |
[aaim][BF4] | 4.3 | — | 亲水 |
[emim][EtSO4] | -65.0 | 0.0962 | 亲水 |
[bmim][PF6] | 10.9 | 0.2740 | 疏水 |
[emim][CH3O(H)PO2] | — | 0.1564 ① | 亲水 |
[hmim][PF6] | -80.0 | 0.4830 | 疏水 |
[C2mim][OAc] | < -20.0 | 0.1285 | 亲水 |
[C4mim]Br | 72.9 | 0.0570 ② | 亲水 |
[P6,6,6,14][BOB] | — | 0.6150 ① | 亲水 |
晶型 | 结晶方法 | 溶剂 | 文献 |
---|---|---|---|
晶型Ⅰ无水物(C20H32N5O8P) | 冷却结晶 | 丙酮+二正丁醚 | [ |
晶型Ⅱ二水合物(C20H32N5O8P·2H2O) | 溶析结晶 | 甲醇/水 | [ |
晶型Ⅲ溶剂化物(C20H32N5O8P·CH3OH) | 蒸发结晶 | 甲醇 | [ |
晶型Ⅳ盐型(C20H32N5O8P·C4H4O4) | 冷却结晶 | 异丙醇+富马酸 | [ |
晶型Ⅴ无水物(C20H32N5O8P) | 喷雾干燥 | 乙醇 | [ |
晶型Ⅵ一水合物(C20H32N5O8P·H2O) | 蒸发结晶 | 二氯甲烷+甲醇+水蒸气 | [ |
晶型Ⅶ溶剂化物(C20H32N5O8P·C4H10O) | 溶析结晶 | 正丁醇/己烷 | [ |
晶型Ⅷ无水物(C20H32N5O8P) | 溶析结晶 | [aeim][BF4]/水 | [ |
晶型Ⅸ半水合物(C20H32N5O8P·0.5H2O) | 溶析结晶 | [aeim][BF4]/水 | [ |
晶型Ⅹ无水物(C20H32N5O8P) | 溶析结晶 | 二氯甲烷/正己烷 | [ |
晶型Ⅺ无水物(C20H32N5O8P) | 溶析结晶 | [aeim][BF4]/[bdmim][BF4] | [ |
晶型 | 结晶方法 | 溶剂 | 文献 |
---|---|---|---|
晶型Ⅰ无水物(C20H32N5O8P) | 冷却结晶 | 丙酮+二正丁醚 | [ |
晶型Ⅱ二水合物(C20H32N5O8P·2H2O) | 溶析结晶 | 甲醇/水 | [ |
晶型Ⅲ溶剂化物(C20H32N5O8P·CH3OH) | 蒸发结晶 | 甲醇 | [ |
晶型Ⅳ盐型(C20H32N5O8P·C4H4O4) | 冷却结晶 | 异丙醇+富马酸 | [ |
晶型Ⅴ无水物(C20H32N5O8P) | 喷雾干燥 | 乙醇 | [ |
晶型Ⅵ一水合物(C20H32N5O8P·H2O) | 蒸发结晶 | 二氯甲烷+甲醇+水蒸气 | [ |
晶型Ⅶ溶剂化物(C20H32N5O8P·C4H10O) | 溶析结晶 | 正丁醇/己烷 | [ |
晶型Ⅷ无水物(C20H32N5O8P) | 溶析结晶 | [aeim][BF4]/水 | [ |
晶型Ⅸ半水合物(C20H32N5O8P·0.5H2O) | 溶析结晶 | [aeim][BF4]/水 | [ |
晶型Ⅹ无水物(C20H32N5O8P) | 溶析结晶 | 二氯甲烷/正己烷 | [ |
晶型Ⅺ无水物(C20H32N5O8P) | 溶析结晶 | [aeim][BF4]/[bdmim][BF4] | [ |
1 | SCHMIDT G M J . Photodimerization in the solid state[J]. Pure and Applied Chemistry,1971, 27(4): 647-678. |
2 | BRAGA D . Crystal engineering, where from? where to?[J]. Chemical Communications, 2003, 39(22): 2751-2754. |
3 | HILFIKER R . Polymorphism:in the pharmaceutical industry[M]. Hoboken:Wiley, 2006: 1-15. |
4 | CHEN J , SARMA B , EVANS J M B , et al . Pharmaceutical crystallization[J]. Crystal Growth & Design, 2011, 11(4): 887-895. |
5 | SARMA B , CHEN J , HIS H Y, et al . Solid forms of pharmaceuticals:polymorphs, salts and cocrystals[J]. Korean Journal of Chemical Engineering, 2011, 28(2): 315-322. |
6 | SUN C C , GRANT D J . Improved tableting properties of p-hydroxybenzoic acid by water of crystallization: a molecular insight[J]. Pharmaceutical Research, 2004, 21(2): 382-386. |
7 | CHANG S Y , SUN C C . Superior plasticity and tabletability of theophylline monohydrate[J]. Molecular Pharmaceutics, 2017, 14(6): 2047-2055. |
8 | CHAROENLARP P , WAIKAGUL J , MUENNOO C , et al . Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and trichuris infections[J]. Southeast Asian Journal of Tropical Medicine & Public Health, 1993, 24(4): 712-716. |
9 | 唐素芳 . 药物多晶型的研究及其对药效和理化性质的影响[J]. 天津药学, 2002, 14(2): 12-14. |
TANG S F . Research on pharmaceutical polymorphs and the influence of efficacy[J]. Tianjin Pharmacy, 2002, 14(2): 12-14. | |
10 | 张伟国, 刘昌孝 . 多晶型药物的生物利用度研究概况[J]. 天津药学, 2007, 19(2): 59-61. |
ZHANG W G , LIU C X . The bioavailability research of pharmaceutical polymorphs[J]. Tianjin Pharmacy, 2007, 19(2): 59-61. | |
11 | DU G H , LV Y , ZHAO Y , et al . New nitrendipine crystal used for treating cardiovascular and cerebrovascular diseases:CN101544596[P]. 2009-09-30. |
12 | 马廷升, 朱兰翠 . 药物生物利用度影响因素的动态分析[J]. 怀化学院学报, 2006, 25(2): 76-77. |
MA T S, ZHU L C . Study on the effective factors of bioavailability[J]. Journal of Huaihua University, 2006, 25(2): 76-77. | |
13 | DESIRAJU G R . Crystal engineering: a holistic view[J]. Angewandte Chemie: International Edition, 2007, 46(44): 8342-8356. |
14 | GAO Z , ROHANI S , GONG J , et al . Recent developments in the crystallization process: toward the pharmaceutical industry[J]. Engineering, 2017, 3(3): 343-353. |
15 | WU S , CHEN M , LI K , et al . Solvent penetration mediated phase transformation for the preparation of aggregated particles with well-defined shape [J]. Cryst. Eng. Comm., 2016, 18(48): 9223-9226. |
16 | TANG W , ZHANG M , MO H , et al . Higher-order self-assembly of benzoic acid in solution[J]. Crystal Growth & Design, 2017, 17(10): 5049-5053. |
17 | GAO Z , ALTIMIMI F , GONG J , et al . Ultrasonic irradiation and seeding to prevent metastable liquid-liquid phase separation and intensify crystallization [J]. Crystal Growth & Design, 2018, 18(4): 2628-2635. |
18 | REICHERT W M , HOLBREY J D , VIGOUR K B , et al . Approaches to crystallization from ionic liquids: complex solvents-complex results, or, a strategy for controlled formation of new supramolecular architectures?[J]. Chemical Communications, 2006, 42(46): 4767-4779. |
19 | HARDACRE C , BOWRON D T , HOLBREY J D , et al . Structure of molten 1, 3-dimethylimidazolium chloride using neutron diffraction[J]. The Journal of Chemical Physics, 2003, 118(1): 273-278. |
20 | HOUGH W L , SMIGLAK M , RODRIGUEZ H , et al . The third evolution of ionic liquids:active pharmaceutical ingredients[J]. New Journal of Chemistry, 2007, 31(8): 1429-1436. |
21 | WELTON T . Room-temperature ionic liquids: solvents for synthesis and catalysis[J]. Chemical Reviews, 1999, 99(8): 2071-2084. |
22 | HALLETT J P , WELTON T . Room-temperature ionic liquids:solvents for synthesis and catalysis. 2 [J]. Chemical Reviews, 2011, 111(5): 3508-3576. |
23 | AHMED E , BRETERNITZ J , GROH M F , et al . Ionic liquids as crystallisation media for inorganic materials[J]. Cryst. Eng. Comm., 2012, 14(15): 4874-4885. |
24 | MEINDERSMA G W , HAAN A B DE . In ionic liquids uncoiled[M]. 8th ed. Hoboken:Wiley, 2013:119. |
25 | CHEN X , JI Y , WANG J . Improvement on the crystallization of lysozyme in the presence of hydrophilic ionic liquid[J]. Analyst, 2010, 135(9): 2241-2248. |
26 | JUDGE R A , TAKAHASHI S , LONGENECKER K L . The effect of ionic liquids on protein crystallization and X-ray diffraction resolution[J]. Crystal Growth & Design, 2009, 9(8): 3463-3469. |
27 | LI X , XU X , FENG Y D J , et al . The crystallization of lysozyme in the system of ionic liquid [BMIm][BF4]-water[J]. Crystal Research and Technology, 2008, 43(10): 1062-1068. |
28 | BARZEGAR M , HABIBI-YANGJEH A , BEHBOUDNIA M . Template-free preparation and characterization of nanocrystalline ZnO in aqueous solution of [EMIM][EtSO4] as a low-cost ionic liquid using ultrasonic irradiation and photocatalytic activity[J]. Journal of Physics and Chemistry of Solids, 2009, 70(10): 1353-1358. |
29 | BARZEGAR M , HABIBI-YANGJEH A , BEHBOUDNIA M . Ultrasonic-assisted preparation and characterization of CdS nanoparticles in the presence of a halide-free and low-cost ionic liquid and photocatalytic activity[J]. Journal of Physics and Chemistry of Solids, 2010, 71(9): 1393-1397. |
30 | ZHAO Y , CHEN Z , WANG H , et al . Crystallization control of CaCO3 by ionic liquids in aqueous solution[J]. Crystal Growth & Design, 2009, 9(11): 4984-4986. |
31 | AN J H , KIM J M, CHANG S M , et al . Application of ionic liquid to polymorphic design of pharmaceutical ingredients[J]. Crystal Growth & Design, 2010, 10(7): 3044-3050. |
32 | AN J H , KIM W S . Antisolvent crystallization using ionic liquids as solvent and antisolvent for polymorphic design of active pharmaceutical ingredient [J]. Crystal Growth & Design, 2013, 13(1): 31-39. |
33 | AN J H , JIN F , KIM H S, et al . Application of ionic liquid to polymorphic transformation of anti-viral/HIV drug adefovir dipivoxil[J]. Archives of Pharmacal Research, 2016, 39(5): 646-659. |
34 | MARTINS I C B , GOMES J R B , DUARTE M T , et al . Understanding polymorphic control of pharmaceuticals using imidazolium-based ionic liquid mixtures as crystallization directing agents[J]. Crystal Growth & Design, 2017, 17(2): 428-432. |
35 | AN J H , JIN F , KIM H S, et al . Investigation of the polymorphic transformation of the active pharmaceutical ingredient clopidogrel bisulfate using the ionic liquid AEImBF4 [J]. Crystal Growth & Design, 2016, 16(4): 1829-1836. |
36 | SMITH K B , BRIDSON R H , LEEKE G A . Crystallisation control of paracetamol from ionic liquids[J]. Cryst. Eng. Comm., 2014, 16(47): 10797-10803. |
37 | HA G S, KIM J H . Effect of an ionic liquid on vancomycin crystallization[J]. Korean Journal of Chemical Engineering, 2015, 32(4): 576-582. |
38 | KARTHIKA S , RADHAKRISHNAN T K , KALAICHELVI P . The role of hydrogen bonding propensity in tuning the morphology of crystals obtained from imidazolium based ionic liquids[J]. Journal of Crystal Growth, 2017, 463:168-175. |
39 | VICOSA A , LETOURNEAU J J , ESPITALIER F , et al . An innovative antisolvent precipitation process as a promising technique to prepare ultrafine rifampicin particles[J]. Journal of Crystal Growth, 2012, 342(1): 80-87. |
40 | AZEVEDO JACQUELINE R DE , ESPITALIER F , LETOURNEAU J J , et al . Antisolvent crystallization of a cardiotonic drug in ionic liquids: effect of mixing on the crystal properties[J]. Journal of Crystal Growth, 2017, 472:29-34. |
41 | GOLOVANOV D G , LYSSENKO K A , ANTIPIN M Y , et al . Cocrystal of an ionic liquid with organic molecules as a mimic of ionic liquid solution[J]. Crystal Growth & Design, 2005, 5(1): 337-340. |
42 | TITI H M , KELLEY S P , EASTON M E , et al . Formation of ionic co-crystals of amphoteric azoles directed by the ionic liquid co-former 1-ethyl-3-methylimidazolium acetate[J]. Chemical Communications, 2017, 53(61): 8569-8572. |
43 | SHIMPI M R , VELAGA S P , SHAH F U , et al . Pharmaceutical crystal engineering using ionic liquid anion-solute interactions[J]. Crystal Growth & Design, 2017, 17(4): 1729-1734. |
44 | KANDULA R K , VEPURI S B , DEVARAJEGOWDA H C , et al . Crystallization of R-(+)-atenolol hydrochloride from racemic ionic liquid - a selective double decomposition green reaction[J]. Journal of Molecular Structure, 2018, 1169: 39-45. |
45 | BYRN S R , PFEIFFER R R , STOWELL J G . Solid-state chemistry of drugs[M]. 2nd ed. West Lafayette:SSCI, 1999: 233-247. |
46 | STOIMENOVSKI J , MACFARLANE D R , BICA K , et al . Crystalline vs. ionic liquid salt forms of active pharmaceutical ingredients: a position paper[J]. Pharmaceutical Research, 2010, 27(4): 521-526. |
47 | CHERUKUVADA S , NANGIA A . Polymorphism in an API ionic liquid:ethambutol dibenzoate trimorphs[J]. Cryst. Eng. Comm., 2012, 14(23): 7840-7843. |
48 | KUMAR V , PARMAR V S , MALHOTRA S V . Enhanced solubility and selective benzoylation of nucleosides in novel ionic liquid[J]. Tetrahedron Letters, 2007, 48(5): 809-812. |
49 | MONIRUZZAMAN M , TAHARA Y , TAMURA M , et al . Ionic liquid-assisted transdermal delivery of sparingly soluble drugs[J]. Chemical Communications, 2010, 46(9): 1452-1454. |
50 | JIANG Y , LIANG M , SVEJKAR D , et al . Albumin-micelles via a one-pot technology platform for the delivery of drugs[J]. Chemical Communications, 2014, 50(48): 6394-6397. |
51 | WINTER K DE , VERLINDEN K , KREN V , et al . Ionic liquids as cosolvents for glycosylation by sucrose phosphorylase: balancing acceptor solubility and enzyme stability[J]. Green Chemistry, 2013, 15(7): 1949-1955. |
52 | USUKI T , YASUDA N , YOSHIZAWA-FUJITA M , et al . Extraction and isolation of shikimic acid from ginkgo biloba leaves utilizing an ionic liquid that dissolves cellulose[J]. Chemical Communications, 2011, 47(38): 10560-10562. |
53 | DAI Y , SPRONSEN J VAN , WITKAMP G J , et al . Natural deep eutectic solvents as new potential media for green technology[J]. Analytica Chimica Acta, 2013, 766(5): 61-68. |
54 | SINTRA T E , SHIMIZU K , VENTURA S P M , et al . Enhanced dissolution of ibuprofen using ionic liquids as catanionic hydrotropes[J]. Physical Chemistry Chemical Physics, 2018, 20(3): 2094-2103. |
55 | SMITH K B , BRIDSON R H , LEEKE G A . Solubilities of pharmaceutical compounds in ionic liquids[J]. Journal of Chemical & Engineering Data, 2011, 56(5): 2039-2043. |
56 | JIN W , YANG Q , ZHANG Z , et al . Self-assembly induced solubilization of drug-like molecules in nanostructured ionic liquids[J]. Chemical Communications, 2015, 51(67): 13170-13173. |
57 | JIA L , XU S , LIU S , et al . Polymorphs of daidzein and intermolecular interaction effect on solution crystallization[J]. Cryst. Eng. Comm., 2017, 19(47): 7146-7153. |
58 | HILDEN J L , REYES C E , KELM M J , et al . Capillary precipitation of a highly polymorphic organic compound[J]. Crystal Growth & Design, 2003, 3(6): 921–926. |
59 | LANG M D , GRZESIAK A L , MATZGER A J . The use of polymer heteronuclei for crystalline polymorph selection[J]. Journal of the American Chemical Society, 2002, 124(50): 14834–14835. |
60 | ARIMILLI M N , LEE T T K, MANES L V , et al . Nucleotide analog compositions:WO9904774A2[P]. 1999-02-04. |
61 | WANG G , LU X , LIU Q , et al . A new crystal form of adefovir dipivoxil and its composition:WO2004043972A1[P]. 2004-05-27. |
62 | GALIMI S , VECCHIO E , PIZZOCZRO R . Adefovir dipivoxil crystalline monohydrate form:WO2009015892A1[P]. 2009-02-05. |
63 | MIN Y S , CHOUL L H . DH-type crystalline form of adefovir dipivoxil, preparing method thereof, and pharmaceutical composition for antiviral agent comprising the same:WO2010110506A1[P]. 2010-09-30. |
64 | AN J H , CHOI G J , KIM W S . Polymorphic and kinetic investigation of adefovir dipivoxil during phase transformation[J]. International Journal of Pharmaceutics, 2012, 422(1): 185-193. |
65 | DAVEY R J , DENT G , MUGHAL R K , et al . Concerning the relationship between structural and growth synthons in crystal nucleation:solution and crystal chemistry of carboxylic acids as revealed through IR spectroscopy[J]. Crystal Growth & Design, 2006, 6(8): 1788-1796. |
66 | IBERS J A . Gabapentin and gabapentin monohydrate[J]. Acta Crystallographica Section C, 2001, 57(5): 641-643. |
67 | REECE H A , LEVENDIS D C . Polymorphs of gabapentin[J]. Acta Crystallographica Section C, 2008, 64(3): o105-o108. |
68 | BRAGA D , GREPIONI F , MAINI L , et al . Polymorphic gabapentin:thermal behaviour, reactivity and interconversion of forms in solution and solid-state[J]. New Journal of Chemistry, 2008, 32(10): 1788-1795. |
69 | KORADLA V , CHAWLA G , BANSAL A . Qualitative and quantitative analysis of clopidogrel bisulphate polymorphs[J]. Acta Pharmaceutica, 2004, 54(3): 193-204. |
70 | KIM H J, KIM K J . Quantitative study on polymorphic form in solution crystallization of clopidogrel hydrogen sulfate[J]. Industrial & Engineering Chemistry Research, 2009, 48(24): 11133-11139. |
71 | QU H M , MUNK T M , CORNETT C , et al . Influence of temperature on solvent-mediated anhydrate-to-hydrate transformation kinetics[J]. Pharmaceutical Research, 2011, 28(2): 364-373. |
72 | MCCABE W L , SMITH J C , HARRIOTT P . Unit operations of chemical engineering[M]. 7th ed. New York:McGraw Hill, 2005:11-15. |
73 | DONG Y , NG W K, SHEN S , et al . Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation[J]. International Journal of Pharmaceutics, 2009, 375(1): 84-88. |
74 | FINNIE S D , RISTIC R I , SHERWOOD J N , et al . Morphological and growth rate distributions of small self-nucleated paracetamol crystals grown from pure aqueous solutions[J]. Journal of Crystal Growth, 1999, 207(4): 308-318. |
75 | YU Z Q , TAN R B H , CHOW P S . Effects of operating conditions on agglomeration and habit of paracetamol crystals in anti-solvent crystallization [J]. Journal of Crystal Growth, 2005, 279(3): 477-488. |
76 | LEE T, KUO C S, CHEN Y H . Solubility, polymorphism, crystallinity, and crystal habit of acetaminophen and ibuprofen:by initial solvent screening[J]. Pharmaceutical Technology, 2006, 30(10): 72-92. |
77 | SMITH K B . Crystallisation of active pharmaceutical ingredients using ionic liquids[D]. Birmingham:University of Birmingham, 2015. |
78 | HUNT PATRICIA A , KIRCHNER B , WELTON T . Characterising the electronic structure of ionic liquids:an examination of the 1-butyl-3-methylimidazolium chloride ion pair[J]. Chemistry:A European Journal, 2006, 12(26): 6762-6775. |
79 | HECQ J , DELEERS M , FANARA D , et al . Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2006, 64(3): 360-368. |
80 | KRAUSE K P , MULLER R H . Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation[J]. International Journal of Pharmaceutics, 2001, 214(1): 21-24. |
81 | WANG Z , CHEN J F , LE Y , et al . Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation[J]. Industrial & Engineering Chemistry Research, 2007, 46(14): 4839-4845. |
82 | RASENACK N , HARTENHAUER H , MULLER B W . Microcrystals for dissolution rate enhancement of poorly water-soluble drugs[J]. International Journal of Pharmaceutics, 2003, 254(2): 137-145. |
83 | ZHANG H X , WANG J X , ZHANG Z B , et al . Micronization of atorvastatin calcium by antisolvent precipitation process[J]. International Journal of Pharmaceutics, 2009, 374(1): 106-113. |
84 | MIZUUCHI H , JAITELY V , MURDAN S , et al . Room temperature ionic liquids and their mixtures:potential pharmaceutical solvents[J]. European Journal of Pharmaceutical Sciences, 2008, 33(4): 326-331. |
85 | DUGGIRALA N K , PERRY M L , ALMARSSON O , et al . Pharmaceutical cocrystals:along the path to improved medicines[J]. Chemical Communications, 2016, 52(4): 640-655. |
86 | AAKEROY C B , FASULO M E , DESPER J . Cocrystal or salt:does it really matter?[J]. Molecular Pharmaceutics, 2007, 4(3): 317-322. |
87 | ALMARSSON O , ZAWOROTKO M J . Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?[J]. Chemical Communications, 2004, 40(17): 1889-1896. |
88 | CLARE SPEAKMAN J . Acid salts of carboxylic acids, crystals with some“very short”hydrogen bonds[C]// Structure and Bonding.Glasgow. 1972. |
89 | BRAGA D , GREPIONI F , MAINI L , et al . From unexpected reactions to a new family of ionic co-crystals:the case of barbituric acid with alkali bromides and caesium iodide[J]. Chemical Communications, 2010, 46(41): 7715-7717. |
90 | KELLEY S P , NARITA A , HOLBREY J D , et al . Understanding the effects of ionicity in salts, solvates, co-crystals, ionic co-crystals, and ionic liquids, rather than nomenclature, is critical to understanding their behavior[J]. Crystal Growth & Design, 2013, 13(3): 965-975. |
91 | ETTER M C . Hydrogen bonds as design elements in organic chemistry[J]. The Journal of Physical Chemistry, 1991, 95(12): 4601-4610. |
92 | WALSH R D B , BRADNER M W , FLEISCHMAN S , et al . Crystal engineering of the composition of pharmaceutical phases[J]. Chemical Communications, 2003, 39(2): 186-187. |
93 | JOHANSSON K M , IZGORODINA E I , FORSYTH M , et al . Protic ionic liquids based on the dimeric and oligomeric anions:[(AcO) x H x -1][J]. Physical Chemistry Chemical Physics, 2008, 10(20): 2972-2978. |
94 | BLAGDEN N , MATAS M DE , GAVAN P T , et al . Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates[J]. Advanced Drug Delivery Reviews, 2007, 59(7): 617-630. |
[1] | WU Ya, ZHAO Dan, FANG Rongmiao, LI Jingyao, CHANG Nana, DU Chunbao, WANG Wenzhen, SHI Jun. Research progress on highly efficient demulsifiers for complex crude oil emulsions and their applications [J]. Chemical Industry and Engineering Progress, 2023, 42(8): 4398-4413. |
[2] | YANG Xuzhao, LI Qing, YUAN Kangkang, ZHANG Yingying, HAN Jingli, WU Shide. Thermodynamic properties of Gemini ionic liquid based deep eutectic solvents [J]. Chemical Industry and Engineering Progress, 2023, 42(6): 3123-3129. |
[3] | LYU Chao, ZHANG Xiwen, JIN Lijian, YANG Linjun. Efficient capture of CO2 by a new biphasic solvent-ionic liquid system [J]. Chemical Industry and Engineering Progress, 2023, 42(6): 3226-3232. |
[4] | CHEN Yu, LIU Chong, QIU Yuhui, BI Zixin, MU Tiancheng. Ionic liquids and deep eutectic solvents for green recycle of spent lithium-ion batteries [J]. Chemical Industry and Engineering Progress, 2022, 41(S1): 485-496. |
[5] | HUA Qucheng, DUAN Qinghua. Research progress of ionic liquid as extreme pressure and anti-wear agent [J]. Chemical Industry and Engineering Progress, 2022, 41(S1): 331-339. |
[6] | HAN Mingyang, QIAO Hui, FU Jiaming, MA Zewen, WANG Yan, OUYANG Jia. Research progress of non-aqueous solvents on the pretreatment of lignocellulose [J]. Chemical Industry and Engineering Progress, 2022, 41(8): 4086-4097. |
[7] | SHAN Qingwen, ZHANG Juan, WANG Yajuan, LIU Wenqiang. Synthesis of polymeric ionic liquid and its performance on adsorption desulfurization [J]. Chemical Industry and Engineering Progress, 2022, 41(8): 4571-4579. |
[8] | RUAN Jiawei, YE Xiangzhu, CHEN Lifang, QI Zhiwen. Recent progress in synthesis of organic carbonates from carbon dioxide catalyzed by ionic liquids and deep eutectic solvents [J]. Chemical Industry and Engineering Progress, 2022, 41(3): 1176-1186. |
[9] | WEI Tingting, WANG Xiankai, ZHAN Yong, CHEN Sisi, DONG Bin. Enhancement of cell lysis in activated sludge by catalytic ozonation of Mn2+ [J]. Chemical Industry and Engineering Progress, 2022, 41(2): 1009-1016. |
[10] | NI Qing, LAI Jinbo, PENG Dongyue, GUAN Cuishi, LONG Jun. Progress in extraction separation of hydrocarbons by ionic liquids [J]. Chemical Industry and Engineering Progress, 2022, 41(2): 619-627. |
[11] | LU Zeping, PEI Xinhua, XUE Yu, ZHANG Xiaoguang, HU Yi. Chemical modification of porcine pancreatic lipase with betaine ionic liquid to improve its enzymatic properties [J]. Chemical Industry and Engineering Progress, 2022, 41(11): 6045-6052. |
[12] | XU Bo, JIANG Guobin, YU Jinlei, HU Jinyan, ZHAO Liang, XU Bingke. Impact of different surfactants on characteristics of single-phase microemulsions [J]. Chemical Industry and Engineering Progress, 2021, 40(S1): 350-356. |
[13] | CHEN Yaju, REN Qinggang, ZHOU Xiantai, JI Hongbing. Recent advances in porous organic polymers for the synthesis of cyclic carbonates from carbon dioxide [J]. Chemical Industry and Engineering Progress, 2021, 40(7): 3564-3583. |
[14] | BAI Ruibing, WANG Junfeng, WANG Daoguang, ZHANG Yanqiang. Research progress of ionic liquid-based extraction separation of lithium from brine [J]. Chemical Industry and Engineering Progress, 2021, 40(6): 3224-3238. |
[15] | LIU Zheng, LIU Ran, HUA Er, JI Jianlong. Water effects on physicochemical properties of protic ionic liquid with N-hexylamine as cation and bis(trifluoromethylsulfonyl) imide as anion [J]. Chemical Industry and Engineering Progress, 2021, 40(4): 2270-2277. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
京ICP备12046843号-2;京公网安备 11010102001994号 Copyright © Chemical Industry and Engineering Progress, All Rights Reserved. E-mail: hgjz@cip.com.cn Powered by Beijing Magtech Co. Ltd |